
Cramik 250mg Injection
Marketer
Alpic Biotech Ltd
Salt Composition
Amikacin (250mg)
Overview Cramik 250mg Injection
Cefak 250mg Injection, an antibacterial medication, combats a broad spectrum of bacterial infections. These encompass infections affecting the urinary system, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream, amongst others. Prophylactic use in hospitalized patients is also indicated. Cefak 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV drip) or via intramuscular injection by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, at evenly spaced intervals, is crucial. Complete the entire course of treatment, even with symptom improvement, to prevent relapse or exacerbation. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or lack of therapeutic response necessitate immediate medical consultation. High doses may, in some cases, induce vertigo, nephrotoxicity, and ototoxicity. Consequently, strict adherence to the physician's instructions is paramount, potentially including regular monitoring of kidney function, hearing, and urinalysis. Use during pregnancy is contraindicated. Disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Cramik 250mg Injection
Infections caused by bacteria
Major Benefits of Cramik 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cramik 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Cramik 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cramik 250mg Injection works:
Cramik 250mg Injection, an antibacterial agent, inhibits bacterial proliferation by disrupting the synthesis of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Cramik 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Cramik 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Cramik 250mg is considered safe for use while breastfeeding. Research in humans indicates minimal transfer of the drug into breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Cramik 250mg Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administration of Cramik 250mg Injection requires careful consideration. A modified dosage of Cramik 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Cramik 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates that dosage modification may not be necessary. Physician consultation is recommended.
What if you forget to take Cramik 250mg Injection :
Omit a scheduled Cramik 250mg Injection? Seek medical advice immediately.
Facts to Know About Cramik 250mg Injection
| Label | Value |
|---|---|
| Type of Compound | Aminoglycoside antibiotics |
| Potential for Dependence | None. |
| Type of Medication | Antimicrobial agents |
| Mechanism of Action | Aminoglycoside antibiotics |
